Literature DB >> 2579155

Genetics of resistance to the African trypanosomes. V. Qualitative and quantitative differences in interferon production among susceptible and resistant mouse strains.

A L de Gee, G Sonnenfeld, J M Mansfield.   

Abstract

The induction of interferon (IFN) was examined in different inbred mouse strains infected with Trypanosoma brucei rhodesiense. Relatively susceptible C3HeB/FeJ mice that do not exhibit variant-specific immunity or control parasitemia did not exhibit detectable IFN throughout the infection. Relatively resistant B10.BR mice that exhibit variant-specific immunity and control the first peak of parasitemia exhibited detectable IFN at two intervals. The appearance of IFN in B10.BR serum first coincided with the onset of the parasitemia 4 days after infection and then disappeared; this IFN peak was predominantly IFN-alpha/beta. The second time of appearance coincided with high titers of antibody and remission of the parasitemia. This IFN was predominantly IFN-gamma. Intermediately susceptible CBA/J mice also exhibited two detectable peaks of IFN; the first IFN-alpha/beta peak coincided with the onset of the parasitemia as in B10.BR mice. The second peak of IFN in the serum of CBA mice, however, was delayed in appearance and lower in concentration compared with B10.BR mice. This peak was characterized as being predominantly IFN alpha/beta. BALB/c mice (also intermediately susceptible) did not exhibit a first peak of IFN-alpha/beta production, but the second peak of IFN-alpha/beta production was similar to that seen in CBA mice. In contrast to infected mice, IFN was induced in both susceptible (C3H) and resistant (B10.BR) mice after immunization with glutaraldehyde-fixed trypanosomes or after chemotherapy of infection. We conclude that both the levels of IFN as well as the type of IFN induced during infection with T. b. rhodesiense depend upon the genetic background of the mouse strain infected. The induction of IFN-gamma in mice of the C57BL background may be linked functionally to more effective parasite control and to the presence of an effective immune response to T. b. rhodesiense.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2579155

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Biological variation among african trypanosomes: I. Clonal expression of virulence is not linked to the variant surface glycoprotein or the variant surface glycoprotein gene telomeric expression site.

Authors:  Jill A Inverso; Timothy S Uphoff; Scott C Johnson; Donna M Paulnock; John M Mansfield
Journal:  DNA Cell Biol       Date:  2010-05       Impact factor: 3.311

2.  Trypanosomes expressing a mosaic variant surface glycoprotein coat escape early detection by the immune system.

Authors:  Melissa E Dubois; Karen P Demick; John M Mansfield
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

3.  Type I IFNs play a role in early resistance, but subsequent susceptibility, to the African trypanosomes.

Authors:  Rebecca Lopez; Karen P Demick; John M Mansfield; Donna M Paulnock
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

4.  Granulocyte-macrophage colony-stimulating activity in the serum of mice stimulated with homogenates of Trypanosoma gambiense.

Authors:  M Oka; H Nagasawa; Y Ito; K Himeno
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

5.  Polyclonal B-cell-activating factors produced by spleen cells of mice stimulated with a cell homogenate of Trypanosoma gambiense.

Authors:  M Oka; Y Ito
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

6.  Interleukin-4-dependent immunoglobulin G1 isotype switch in the presence of a polarized antigen-specific Th1-cell response to the trypanosome variant surface glycoprotein.

Authors:  L R Schopf; H Filutowicz; X J Bi; J M Mansfield
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

7.  Cytokine gene expression in innately susceptible BALB/c mice and relatively resistant C57BL/6 mice during infection with virulent Burkholderia pseudomallei.

Authors:  G C Ulett; N Ketheesan; R G Hirst
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

8.  Distinct Contributions of CD4+ and CD8+ T Cells to Pathogenesis of Trypanosoma brucei Infection in the Context of Gamma Interferon and Interleukin-10.

Authors:  Gongguan Liu; Donglei Sun; Hui Wu; Mingshun Zhang; Haixia Huan; Jinjun Xu; Xiquan Zhang; Hong Zhou; Meiqing Shi
Journal:  Infect Immun       Date:  2015-04-27       Impact factor: 3.441

9.  Modulation of infection by gamma interferon treatment following trauma.

Authors:  M J Hershman; H C Polk; J D Pietsch; R E Shields; S R Wellhausen; G Sonnenfeld
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

10.  H-2-linked control of in vitro gamma interferon production in response to a 32-kilodalton antigen (P32) of Mycobacterium bovis bacillus Calmette-Guérin.

Authors:  K Huygen; K Palfliet; F Jurion; J Hilgers; R ten Berg; J P Van Vooren; J De Bruyn
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.